Biocytogen/Eucure Biopharma to Present Clinical Data from YH00...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BEIJING dldate May 24, 2022 /PRNewswire - AsiaNet/ -- Eucure Biopharma, a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen"), today announced that it will present two posters at the 2022 ASCO Annual Meeting, taking place in Chicago, IL and virtually from June 3-7...
Authors: LATEST ASIANET NEWS RELEASES